Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19.
Rhodes NJ, Dairem A, Moore W, Shah A, Postelnick MJ, Badowski ME, Michienzi SM, Borkowski JL, Polisetty RS, Fong K, Spivek ES, Beardsley JR, Hale CM, Pallotta AM, Srinivas P, Schulz LT.
Rhodes NJ, et al. Among authors: schulz lt.
medRxiv [Preprint]. 2020 Jun 5:2020.06.03.20121558. doi: 10.1101/2020.06.03.20121558.
medRxiv. 2020.
PMID: 32577687
Free PMC article.
Updated.
Preprint.